Ardelyx (ARDX) – Hot FDA News
-
Ardelyx (ARDX) falls 27% after saying will not apply to include XPHOZAH in CMS ESRD PPS TDAPA
-
Ardelyx (ARDX) Announces Tenapanor for Hyperphosphatemia Approved in Japan
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARDX Stock Lookup